Events
Mdma events
MDMA’s four flagship events – our FDA Forum, Annual Meeting, Executive Forum, and Reimbursement & Health Policy Conference – have become must-attend conferences for medical technology executives and are open to members and non-members alike. Whether your goal is to advocate for specific policies, learn the latest developments from industry leaders, or network with fellow MedTech professionals, an upcoming MDMA event will deliver value to you and your colleagues. MDMA members also receive opportunities to attend member-only meetings, webinars, roundtables, and more.
featured events
MDMA Partner events
There are no items available at this time. Please check back soon.
Past events
April 29, 2026
MDMA Annual Meeting
MDMA hosted another successful Annual Meeting in Washington, DC with 250 medtech executives! Attendees heard firsthand from FDA Commissioner Dr. Marty Makary, CMS Administrator Dr. Mehmet Oz, CDRH Director Dr. Michelle Tarver, Deputy Administrator and Chief Policy & Regulatory Officer of CMS John Brooks, American Medical Association CEO Dr. John Whyte, and many more.
March 12, 2026
MDMA 2026 FDA Forum
MDMA hosted a successful FDA Forum this week where over 125 attendees networked while learning the latest strategies and insights from 12 senior FDA officials and some of our industry’s leading regulatory experts.
November 13, 2025
MDMA 2025 Reimbursement & Health Policy Conference
MDMA's 28th Annual Reimbursement and Health Policy Conference was held in Washington, DC, and once again was SOLD OUT! MDMA's longest running conference hosted some of the industry's and government's leading voices on issues related to market access, providing an interactive
September 26, 2025
MDMA 2025 Medical Technology Executive Forum Registration
MDMA hosted over 140 attendees in Palo Alto, CA at our FDA Forum, which continues to grow as the leading policy and regulatory oriented conference designed specifically for medtech regulatory professionals. Attendees networked while learning the latest strategies and insights from industry regulatory experts. Industry leaders held interactive panels focusing on key issues such as biocompatibility, cybersecurity, artificial intelligence, MDUFA implementation, and general strategies for navigating the changing landscape at FDA.